Abstract:The mechanism of action of retinoic acid (RA) is of broad relevance to cell and developmental biology, nutrition, and cancer chemotherapy. RA is known to induce expression of the Burkitt's lymphoma receptor 1 (BLR1) gene which propels RA-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells, motivating the present analysis of transcriptional regulation of blr1 expression by RA. The RA-treated HL-60 cells used here expressed all RA receptor (RAR) and retinoid X receptor (RXR) subtypes (as detected by Northern analysis) except RXRgamma. Treatment with RAR- and RXR-selective ligands showed that RARalpha synergized with RXRalpha to transcriptionally activate blr1 expression. A 5'-flanking region capable of supporting RA-induced Nil activation in HL-60 cells was found to contain a 205-bp sequence in the distal portion that was necessary for transcriptional activation by RA. Within this sequence DNase I footprinting revealed that RA induced binding of a nuclear protein complex to an element containing two GT boxes. Electromobility shift assays (EMSAs) and supershift assays showed that this element bound recombinant RARalpha and RXRalpha. Without RA there was neither complex binding nor transcriptional activation. Both GT boxes were needed for binding the complex, and mutation of either GT box caused the loss of transcriptional activation by RA. The ability of this cis-acting RAR-RXR binding element to activate transcription in response to RA also depended on downstream sequences where an octamer transcription factor 1 (Oct1) site and a nuclear factor of activated T cells (NFATc) site between this element and the transcriptional start, as well as a cyclic AMP response element binding factor (CREB) site between the transcriptional start and first exon of the blr1 gene, were necessary. Each of these sites bound its corresponding transcription factor. A transcription factor-transcription factor binding array analysis of nuclear lysate from RA-treated cells indicated several prominent RARalpha binding partners; among these, Oct1, NFATc3, and CREB2 were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex. RA upregulated expression of these three factors. In sum the results of the present study indicate that RA-induced expression of Nil expression depends on a novel RA response element. This cis-acting element approximately 1 kb upstream of the transcriptional start consists of two GT boxes that bind RAR and RXR in a nuclear protein complex that also contains Oct1, NFATc3, and CREB2 bound to their cognate downstream consensus binding sites.

Retinoic acid mediates the expression of glutamate transporter‐1 in rat astrocytes through genomic RXR action and non‐genomic protein kinase C signaling pathway

Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression

Multiple Retinol and Retinal Dehydrogenases Catalyze All-trans-retinoic Acid Biosynthesis in Astrocytes

Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis

Energy status regulates levels of the RAR/RXR ligand 9-cis-retinoic acid in mammalian tissues: Glucose reduces its synthesis in β-cells

Retinoic Acid Regulates CD1d Gene Expression at the Transcriptional Level in Human and Rodent Monocytic Cells.

Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes Through the Retinoid X Receptor/retinoic Acid Receptor Pathway.

Retinoic acid modulation of granule cell activity and spatial discrimination in the adult hippocampus

P38 Mitogen-Activated Protein Kinase-Dependent Regulation of Src-3 and Involvement in Retinoic Acid Receptor Alpha Signaling in Embryonic Cortical Neurons

Retinoic acid inhibits the angiogenesis of human embryonic stem cell-derived endothelial cells by activating FBP1-mediated gluconeogenesis

Rapamycin Prevents the Mutant Huntingtin-Suppressed GLT-1 Expression in Cultured Astrocytes

Differentially Expressed Genes from the Glioblastoma Cell Line Shg-44 Treated with All-Trans Retinoic Acid in Vitro

All-trans Retinoic Acid Increased Transglutaminase 2 Expressions in BV-2 Cells and Cultured Astrocytes

A Liver X Receptor And Retinoid X Receptor Heterodimer Mediates Apolipoprotein E Expression, Secretion And Cholesterol Homeostasis In Astrocytes

Activation of PPARα enhances astroglial uptake and degradation of β-amyloid

Retinoic Acid Improves Nephrotoxic Serum-Induced Glomerulonephritis Through Activation of Podocyte Retinoic Acid Receptor Α.

A Novel Retinoic Acid-Responsive Element Regulates Retinoic Acid-Induced BLR1 Expression.

Retinoic acid induced specific changes in the phosphoproteome of C17.2 neural stem cells

All-trans Retinoic Acid Inhibits the Increases in Fibronectin and PAI-1 Induced by TGF-β1 and Ang II in Rat Mesangial Cells

Β-Hydroxybutyrate Enhances Astrocyte Glutamate Uptake Through EAAT1 Expression Regulation

The Pattern of Retinoic Acid Receptor Expression and Subcellular, Anatomic and Functional Area Translocation During the Postnatal Development of the Rat Cerebral Cortex and White Matter